These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27699467)
21. Isolated autonomic failure without evident somatic polyneuropathy in AL amyloidosis. Sugiyama A; Asahina M; Takeda Y; Shiojiri T; Sano K; Ikeda S; Kuwabara S Amyloid; 2014 Sep; 21(3):218-20. PubMed ID: 24970351 [No Abstract] [Full Text] [Related]
22. Serial monitoring of basal metabolic rate for therapeutic evaluation in an Isaacs' syndrome patient with chronic fluctuating symptoms. Hayashi Y; Kimura A; Watanabe N; Yamada M; Sakurai T; Tanaka Y; Hozumi I; Inuzuka T Intern Med; 2010; 49(5):475-7. PubMed ID: 20190487 [TBL] [Abstract][Full Text] [Related]
23. Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case. Tanabe H; Maki Y; Urabe S; Higuchi I; Obayashi K; Hokezu Y Muscle Nerve; 2015 Dec; 52(6):1113-7. PubMed ID: 26179325 [TBL] [Abstract][Full Text] [Related]
24. Primary AL amyloidosis presenting with systemic lymphadenopathy with calcification. Fujita T; Ichikawa S; Okitsu Y; Fukuhara N; Yoshinaga T; Yazaki M; Harigae H Int J Hematol; 2016 Dec; 104(6):641-643. PubMed ID: 27631125 [No Abstract] [Full Text] [Related]
25. Myopathy due to primary systemic amyloidosis. Aggarwal A; Corbett A J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):385. PubMed ID: 10675229 [No Abstract] [Full Text] [Related]
26. Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid. Riveiro-Barciela M; Martínez-Valle F; Vilardell-Tarrés M J Am Geriatr Soc; 2012 Oct; 60(10):1974-5. PubMed ID: 23057449 [No Abstract] [Full Text] [Related]
27. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy. Gertz MA; Grogan M; Kyle RA; Tajik AJ Am J Cardiol; 1997 Jul; 80(1):93-5. PubMed ID: 9205031 [TBL] [Abstract][Full Text] [Related]
29. Isaacs syndrome with CASPR2 antibody: A series of three cases. Song J; Jing S; Quan C; Lu J; Qiao X; Qiao K; Lu J; Xi J; Zhao C J Clin Neurosci; 2017 Jul; 41():63-66. PubMed ID: 28438465 [TBL] [Abstract][Full Text] [Related]
31. [Myopathy and mixed hyperlipoproteinemia as the first symptom of systemic AL-amyloidosis]. Tosovský M; Soukup T; Bradna P; Maisnar V; Tycová V; Toms J; Prixová M Vnitr Lek; 2008 Oct; 54(10):1014-9. PubMed ID: 19009771 [TBL] [Abstract][Full Text] [Related]
32. Isaacs' syndrome in a patient with dermatomyositis: case report and review of the literature. Lertnawapan R; Kulkantrakorn K Int J Rheum Dis; 2017 Aug; 20(8):1039-1045. PubMed ID: 27135791 [TBL] [Abstract][Full Text] [Related]
33. Acquired neuromyotonia (Isaacs' syndrome): a case report with autonomic physiologic studies. Sukajintanakarn D; Mitrabhakdi E; Phanthumchinda K J Med Assoc Thai; 2006 Aug; 89(8):1308-12. PubMed ID: 17048446 [TBL] [Abstract][Full Text] [Related]
35. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy. Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779 [TBL] [Abstract][Full Text] [Related]
39. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept. Ramirez-Alvarado M; Barnidge DR; Murray DL; Dispenzieri A; Marin-Argany M; Dick CJ; Cooper SA; Nasr SH; Ward CJ; Dasari S; Jiménez-Zepeda VH; Leung N Am J Hematol; 2017 Jun; 92(6):536-541. PubMed ID: 28295502 [TBL] [Abstract][Full Text] [Related]
40. Isaacs' syndrome: clinical and electrophysiological response to gabapentin. Dhand UK Muscle Nerve; 2006 Nov; 34(5):646-50. PubMed ID: 16770779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]